aibio
Distress ·
America Great Health says it cannot file its annual report by September 30, 2026
The company filed a late-filing notice for the year ended June 30, 2026. It says it has not been able to compile the financial data for its Form 10-K.
AAGH America Great Health
America Great Health (AAGH) news AAGH Nasdaq notice news
Latest America Great Health news
We have not published a story on America Great Health yet. When there is news, it will appear here.
What America Great Health does
America Great Health, formerly Crown Marketing, is a Wyoming corporation. A change of control was completed on January 19, 2017, and since then its operations have been determined by a new investor group. The company says its focus is the health industry, with a mission to invest in innovative technologies integrated with business development in the healthcare ecosystem. It describes its areas as protein and peptide small molecular drugs research and development, diagnostics and medical devices with AI cloud computing, cell therapy, regenerative medicine, and supplements manufacturing and sales. Its activities include an equity interest in Purecell, an anti-aging medical institution in Australia, and a joint venture in China, Sijinsai (Hainan) Biological Tech Ltd., formed with Brilliant Healthcare Limited to develop stem cell related products. Its subsidiary GOF Biotechnologies Inc. works on oral insulin and Amylase X, using technology from David Tsai, a researcher in anti-cancer peptides. The company has five full-time employees.
| Product or program | What it is | Stage |
|---|---|---|
| Oral insulin | Oral insulin under development at GOF Biotechnologies | |
| Amylase X | Product under development at GOF Biotechnologies |
America Great Health annual financials
Questions about America Great Health
Has America Great Health received a Nasdaq deficiency notice?
Our latest story on this, dated Sep 25, 2026: "America Great Health says it cannot file its annual report by September 30, 2026". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of America Great Health?
America Great Health trades under the ticker AAGH on OTC.
Where is America Great Health listed?
America Great Health is listed on OTC.
What is the SEC CIK of America Great Health?
The SEC Central Index Key (CIK) for America Great Health is 1098009. Its filings are on SEC EDGAR.
How many shares does America Great Health have outstanding?
21,204,811,608 shares as of 2026-08-04, per the cover page of its 10-Q filed 2026-08-06.
Which country or territory is America Great Health listed under?
Our directory records America Great Health under United States.
What does America Great Health do?
Our directory classifies America Great Health as: Mixed biopharma / other operations. This is a directory classification, not a description of the pipeline.
What is the ISIN of America Great Health?
The ISIN recorded for America Great Health is US02365T1016.
Does aibio.space cover America Great Health?
aibio.space lists America Great Health among 2,820 public biotech companies and publishes its news here as stories appear.
Where is America Great Health incorporated?
SEC records list its state or country of incorporation as CA.
What does America Great Health develop?
America Great Health, formerly Crown Marketing, is a Wyoming corporation. A change of control was completed on January 19, 2017, and since then its operations have been determined by a new investor group.
What is Oral insulin from America Great Health?
Oral insulin: Oral insulin under development at GOF Biotechnologies
What is Amylase X from America Great Health?
Amylase X: Product under development at GOF Biotechnologies
What was America Great Health's revenue last year?
$391,743 for the fiscal year ended Jun 30, 2025, as reported to the SEC.
Is America Great Health profitable?
America Great Health reported a net loss of $719,119 for the fiscal year ended Jun 30, 2025, and used $332,862 of cash in operations, per its annual report to the SEC.
Investor discussion: America Great Health
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
Stock chart
SEC filings and registration
- SEC name
- America Great Health
- CIK
- 1098009
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- AAGH (OTC)
- State or country of incorporation
- CA
- Fiscal year ends
- June 30
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Business address
- 1609 W VALLEY BLVD UNIT 338A, ALHAMBRA, CA, 91803
- Phone
- (888) 988-1333
- Shares outstanding
- 21,204,811,608 as of 2026-08-04 (10-Q filed 2026-08-06)
- Former names
- CROWN MARKETING; SPACE LAUNCHES FINANCING INC
Recent filings
Listing details
- Company
- America Great Health
- Ticker
- AAGH
- Listing
- OTC
- Country or territory
- United States
- Business scope
- Mixed biopharma / other operations
- ISIN
- US02365T1016
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction